Five years on, proposal to amend act on misleading ads still on hold: RTI
NEW DELHI: Five years ago, the Union Health Ministry proposed significant changes to amend the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, which aimed to take stringent action against misleading advertisements, including those of Ayush medicines.
However, an RTI has revealed that the ministry seems to have kept it in cold storage, as there has been no movement after November 2022.
The amendments to the DMR (Objectionable Advertisement) Act, 1954, proposed widening the scope of the Act by introducing 24 more diseases and disorders, including drugs for treatment for enhancing sexual performance, and fairness of skin. The act applies to all drugs, including Ayurvedic, Siddha, Unani, and Homoeopathy medicines.
Replying to an RTI filed by activist, Dr KV Babu, the Union Health Ministry on May 15 said, 'As per available records, no noting has been recorded after 09/11/2022 in File No A.11035/133/2014-DFQC.'
The Kerala-based ophthalmologist said, 'The draft proposal was put on the public domain in February 2020 following criticism of Parliamentary Standing Committee in 2018. Instead of 54 diseases, the scope was widened to 78 diseases and disorders and the punishment was enhanced to two years and five years, instead of six months and one year.'
'The proposed amendment has been under suspended animation for more than five years, and there is no file movement after November 2022,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
HC quashes govt. order on collection of fees from medical interns
The Kerala High Court has set aside the State government's order imposing internship fee on foreign medical graduates for doing their compulsory rotatory medical Internship (CRMI) in government hospitals. Justice N. Nagaresh passed the order recently while allowing writ petitions filed by students who completed their medical degree courses in countries such as Russia, Bulgaria, the Philippines, and Guyana. According to the petitioners, no fees can be collected from the foreign medical graduates in light of the circular of the National Medical Commission. The government was collecting ₹5,000 a month as fees. The court observed that when the National Medical Commission (NMC) Act mandated payment of stipends to medical interns for their services, the State government was not justified in imposing internship fees on them.
Hans India
2 hours ago
- Hans India
Ayush Nivesh Saarthi portal signals India's readiness in holistic healthcare: Piyush Goyal
New Delhi: The newly launched Ayush Nivesh Saarthi portal is rooted in tradition and signals India's readiness for holistic healthcare, Commerce and Industry Minister Piyush Goyal has said. Developed by the Ministry of Ayush in collaboration with Invest India, Ayush Nivesh Saarthi is a dedicated, investor-centric digital platform. It brings together policy frameworks, incentive structures, investment-ready projects, and real-time facilitation under one unified interface. It is designed to support both domestic and global investors, the platform is a strategic tool that strengthens India's standing as a global investment destination for traditional systems of medicine. The Ayush Nivesh Saarthi portal was launched on May 29 during the Ayush stakeholder/industry interaction meeting held at Vanijya Bhawan, New Delhi. The historic move positions India as the global epicentre for traditional medicine and wellness. 'With 100 per cent FDI permitted in the Ayush sector through the automatic route, the launch of Ayush Nivesh Saarthi is a signal to the world that India is open for investment, collaboration, and innovation in holistic healthcare,' said Piyush Goyal, during the launch. 'India's Ayush ecosystem is rooted in deep tradition but is powered by modern vision. Through this portal, we are not only connecting investors with opportunities but with India's ancient legacy of wellness,' he added. The Ayush industry has emerged as one of the fastest-growing sectors in the country, recording an annual growth of 17 per cent between 2014 and 2020. With rising global consumer interest in natural, preventive, and wellness-based healthcare, Ayush is at the forefront of a new wave in global health and lifestyle transformation. 'Ayush Nivesh Saarthi is more than a digital platform -- it is an enabler of transformation. It brings together the government's proactive policies, India's natural wealth of over 8,000 medicinal plant species, and a globally trusted wellness tradition,' said Prataprao Jadhav, Union Minister of State (Independent Charge) for Ayush. 'This portal will empower investors with real-time data, transparent policy guidance, and access to a vibrant, expanding market. Ayush is no longer just India's heritage -- it's now a global opportunity,' Jadhav added. The Ayush sector's relevance is also strongly reflected in its contributions to medical value travel (MVT) and the global wellness economy. Ranked among the top five health services in India, Ayush is a key driver of the country's $13 billion MVT sector globally. The new investor facilitation portal is expected to serve as a vital catalyst in attracting foreign direct investment, empowering entrepreneurs, and showcasing India's leadership in traditional medicine and wellness to the world. Ayush Nivesh Saarthi, Holistic Healthcare, Piyush Goyal, Traditional Medicine, Investment Platform, India Ayush Sector
NDTV
6 hours ago
- NDTV
Covid-19 In India: Do's And Don'ts To Stay Safe
India recorded 564 fresh Covid-19 cases in the last 24 hours. The total number of active Covid-19 cases stands at 4,866 as of Thursday morning, with Kerala remaining the most affected State, followed by Maharashtra, Gujarat, and Delhi, according to the Union Health Ministry data. At least 7 deaths were reported during the current resurgence of Covid-19 infection. No need to panic, said experts Doctors and health officials in India and across the world have said that the new Covid variants are not serious threats but are spreading faster. Director General of the Indian Council of Medical Research (ICMR) Dr Rajiv Behl also said that the severity of infections is currently generally mild and there is no cause for worry. He also mentioned that Omicron Sub-variants LF.7, XFG, JN.1, and NB. 1.8.1 are currently circulating and are not severe. Why should you do? As cases are rising rapidly in India, it is important for all to follow safety precautions that can help you stay safe. Here are some government guidelines you should follow: Do's Wash your hands frequently with soap and water or use alcohol-based hand rub with at least 60% alcohol. Wear a mask Cover your nose and mouth with a handkerchief/tissue while sneezing and coughing. Throw used tissues into closed bins immediately after use. Avoid mass gatherings and crowded places. Wash your hands before touching your eyes, nose and mouth. See a doctor if you feel unwell. Do not ignore symptoms like fever, difficulty breathing and cough. While visiting doctor wear a mask/cloth to cover your mouth and nose. Don'ts Avoid touching surfaces that might be contaminated. Do not ignore symptoms and delay testing. Do not come in close contact with anyone who is sick. Avoid shaking hands Don't allow visitors at home or visit someone else's home. As of May 2025, the World Health Organization (WHO) classifies LF.7 and NB.1.8 sub-variants as Variants Under Monitoring, not as Variants of Concern or Variants of Interest. But these are spreading rapidly and a rise in hospitalisation has been observed in China and other parts of Asia. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
